The trademark application Lacrifast was filed by ROHTO Pharmaceutical Co., Ltd., a corporation established under the laws of Japan (the "Applicant"). The application was published for oppositions on February 8, 2023, and it was registered by office on May 18, 2023 without any oppositions.
The application was filed in English (German was selected as the second language).